Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cardiovascular Disorders
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Public Health | Research article

Reasons for poor blood pressure control in Eastern Sub-Saharan Africa: looking into 4P’s (primary care, professional, patient, and public health policy) for improving blood pressure control: a scoping review

Authors: Mende Mensa Sorato, Majid Davari, Abbas Kebriaeezadeh, Nizal Sarrafzadegan, Tamiru Shibru, Behzad Fatemi

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Aim

Hypertension control in Sub-Saharan Africa (SSA) is the worst (less than one out of ten) when compared to the rest of the world. Therefore, this scoping review was conducted to identify and describe the possible reasons for poor blood pressure (BP) control based on 4Ps’ (patient, professional, primary healthcare system, and public health policy) factors.

Methods

PRISMA extension for scoping review protocol was used. We systematically searched articles written in the English language from January 2000 to May 2020 from the following databases: PubMed/Medline, Embase, Scopus, Web of Science, and Google scholar.

Results

Sixty-eight articles were included in this scoping review. The mean prevalence of hypertension, BP control, and patient adherence to prescribed medicines were 20.95%, 11.5%, and 60%, respectively. Only Kenya, Malawi, and Zambia out of ten countries started annual screening of the high-risk population for hypertension. Reasons for nonadherence to prescribed medicines were lack of awareness, lack of access to medicines and health services, professional inertia to intensify drugs, lack of knowledge on evidence-based guidelines, insufficient government commitment, and specific health behaviors related laws. Lack of screening for high-risk patients, non-treatment adherence, weak political commitment, poverty, maternal and child malnutrition were reasons for the worst BP control.

Conclusion

In conclusion, the rate of BP treatment, control, and medication adherence was low in Eastern SSA. Screening for high-risk populations was inadequate. Therefore, it is crucial to improve government commitment, patient awareness, and access to medicines, design country-specific annual screening programs, and empower clinicians to follow individualized treatment and conduct medication adherence research using more robust tools.
Appendix
Available only for authorised users
Literature
1.
Collaborators GRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923.CrossRef
2.
Carvalho JV, Rocha Á, Abreu A. Maturity models of healthcare information systems and technologies: a literature review. J Med Syst. 2016;40(6):131.PubMedCrossRef
3.
Seedat YK. Impact of poverty on hypertension and cardiovascular disease in sub-Saharan Africa. Cardiovasc J Afr. 2007;18(5):316–20.PubMedPubMedCentral
4.
Collaborators GRF. Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923–94.CrossRef
5.
Region WSEA. Special issue on blood pressure-take control. India 2013 World Health Day.
6.
Geldsetzer P, Manne-Goehler J, Marcus M-E, Ebert C, Zhumadilov Z, Wesseh CS, Tsabedze L, Supiyev A, Sturua L, Bahendeka SK, Sibai AM, Quesnel-Crooks S, Norov B, Mwangi KJ, Mwalim O, Wong-McClure R, Mayige MT, Martins JS, Jaacks LM. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet. 2019;6736(19):30955–9.
7.
Mohamed SF, Uthman OA, Caleyachetty R, Chumo I, Mutua MK, Asiki G, et al. Uncontrolled hypertension among patients with comorbidities in sub-Saharan Africa: protocol for a systematic review and meta-analysis. Syst Rev. 2020;9(1):16.PubMedPubMedCentralCrossRef
8.
Volpe M, Savoia C. Natural history of treated and untreated hypertension. In: Berbari AE, Mancia G, editors. Disorders of blood pressure regulation: phenotypes, mechanisms, therapeutic options. Springer; 2018. p. 33–44.CrossRef
9.
Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens. 2008;10:20–6.CrossRef
10.
Saleh S, Alameddine M, Mourad Y, Natafgi N. Quality of care in primary health care settings in the Eastern Mediterranean region: a systematic review of the literature. Int J Qual Health Care. 2015;27(2):79–88.PubMed
11.
Katz A, Chateau D, Enns JE, Valdivia J, Taylor C, Walld R, et al. Association of the social determinants of health with quality of primary care. Ann Fam Med. 2018;16(3):217–24.PubMedPubMedCentralCrossRef
12.
Ludt S, Campbell SM, Petek D, Rochon J, Szecsenyi J, Van Lieshout J, et al. Which practice characteristics are associated with the quality of cardiovascular disease prevention in European primary care? Implement Sci. 2013;8(1):27.PubMedPubMedCentralCrossRef
13.
Antignac M, Diop IB, Macquart de Terline D, Kramoh KE, Balde DM, Dzudie A, et al. Socioeconomic status and hypertension control in Sub-Saharan Africa: the multination EIGHT study (evaluation of hypertension in sub-Saharan Africa). Hypertension. 2018;71(4):577–84.PubMedCrossRef
14.
Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-Saharan Africa. A systematic review and meta-analysis. Hypertension. 2014;65:291–8.PubMedCrossRef
15.
Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension. 2015;65(2):291–8.PubMedCrossRef
16.
World Health Organization. It’s time to walk the talk: WHO independent high-level commission on noncommunicable diseases final report. World Health Organization; 2019.
17.
Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143.PubMedPubMedCentralCrossRef
18.
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MD, Horsley T, Weeks L, Hempel S. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.PubMedCrossRef
19.
Lange G-M, Wodon Q, Carey K. The changing wealth of nations 2018: Building a sustainable future: The World Bank; 2018.
20.
Bongaarts J. Global and regional population projections to 2025. Population and food in the early twenty first century. International Food Policy Research Institute; 1995. p. 7–16.
21.
Institute EPH. Ethiopia steps report on risk factors for chronic non-communicable diseases and prevalence of selected NCDs. 2016.
22.
Dadi AF, Desyibelew HD. Undernutrition and its associated factors among pregnant mothers in Gondar town, Northwest Ethiopia. PLoS ONE. 2019;14(4):e0215305-e.CrossRef
23.
Birlew T, Alemseged F. Risk factors for hypertension among adults. An analysis of survey data on chronic non-communicable disease at Gilgel gibe field research center, south west Ethiopia. Science. 2015;3(2):281–90.
24.
Organization WH. Noncommunicable diseases country profiles 2018. 2018.
25.
Salam RA, Syed B, Syed S, Das JK, Zagre NM, Rayco-Solon P, et al. Maternal nutrition: how is Eastern and Southern Africa faring and what needs to be done? Afr Health Sci. 2015;15(2):532–45.PubMedPubMedCentralCrossRef
26.
Msyamboza KP, Ngwira B, Dzowela T, Mvula C, Kathyola D, Harries AD, et al. The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey. PLoS ONE. 2011;6(5):e20316.PubMedPubMedCentralCrossRef
27.
Mwenda V, Mwangi M, Nyanjau L, Gichu M, Kyobutungi C, Kibachio J. Dietary risk factors for non-communicable diseases in Kenya: findings of the STEPS survey, 2015. BMC Public Health. 2018;18(3):1218.PubMedPubMedCentralCrossRef
28.
Olack B, Wabwire-Mangen F, Smeeth L, Montgomery JM, Kiwanuka N, Breiman RF. Risk factors of hypertension among adults aged 35–64 years living in an urban slum Nairobi, Kenya. BMC Public Health. 2015;15(1):1251.PubMedPubMedCentralCrossRef
29.
Surveillance WSndrf. Non communicable diseases risk factors steps survey Kenya, fact sheet. 2015.
30.
Silva-Matos C, Beran D. Non-communicable diseases in Mozambique: risk factors, burden, response and outcomes to date. Glob Health. 2012;8(1):37.CrossRef
31.
Nahimana M-R, Nyandwi A, Muhimpundu MA, Olu O, Condo JU, Rusanganwa A, et al. A population-based national estimate of the prevalence and risk factors associated with hypertension in Rwanda: implications for prevention and control. BMC Public Health. 2018;18(1):2.CrossRef
32.
Bovet P, Viswanathan B, Louange M, Gedeon J. National survey of noncommunicable diseases in Seychelles, 2013–2014 (Seychelles Heart Study IV): methods and main findings. Ministry of Health; 2015.
33.
Mayige M, Kagaruki G. Tanzania STEPS survey report. National Institute of Medical Research; 2013.
34.
Wesonga R, Guwatudde D, Bahendeka SK, Mutungi G, Nabugoomu F, Muwonge J. Burden of cumulative risk factors associated with non-communicable diseases among adults in Uganda: evidence from a national baseline survey. Int J Equity Health. 2016;15(1):195.PubMedPubMedCentralCrossRef
35.
36.
37.
Mukanu MM. Government’s health policy response to non-communicable diseases in Zambia. The University of Zambia; 2016.
38.
Hakim J, Mujuru N, Rusakaniko S, Gomor Z. National survey Zimbabwe non-communicable disease risk factors-(ZiNCoDs) Preliminary report using the WHO STEPwise approach to surveillance of non-communicable diseases (STEPS). Harare: Ministry of Health & Child Welfare and The University of Zimbabwe; 2005.
39.
Mutowo MP, Mangwiro JC, Lorgelly PK, Owen AJ, Renzaho A. Hypertension in Zimbabwe: a meta-analysis to quantify its burden and policy implications. World J Meta-Anal. 2015;3(1):54–60.CrossRef
40.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). Eur Heart J. 2016;37:2315–81.PubMedPubMedCentralCrossRef
41.
Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3(12):e003733.PubMedPubMedCentralCrossRef
42.
Organization WH. The SHAKE technical package for salt reduction. 2016.
43.
Organization WH. Noncommunicable diseases progress monitor 2017. WHO, 2018. 2017.
44.
Heydari G, Chamyani F, Masjedi MR, Fadaizadeh L. Comparison of Tobacco Control Programs Worldwide: a quantitative analysis of the 2015 World Health Organization MPOWER report. Int J Prev Med. 2016;7:127.PubMedPubMedCentralCrossRef
45.
Non-Communicable O. National Strategic Action Plan (NSAP) for prevention & control of non-communicable diseases in Ethiopia.
46.
Sorato MM, Davari M, Kebriaeezadeh A. Health care system response to cardiovascular diseases, trends from 2010–2018: can Ethiopia achieve 2025 global voluntary targets for non-communicable diseases from cardiovascular diseases perspective? Explanatory review of available literatures. Res Rev J Med Health Sci. 2019;9(1):1–13.
47.
Asiki G, Shao S, Wainana C, Khayeka-Wandabwa C, Haregu TN, Juma PA, et al. Policy environment for prevention, control and management of cardiovascular diseases in primary health care in Kenya. BMC Health Serv Res. 2018;18(1):344.PubMedPubMedCentralCrossRef
48.
Juma PA, Mohamed SF, Matanje Mwagomba BL, Ndinda C, Mapa-tassou C, Oluwasanu M, et al. Non-communicable disease prevention policy process in five African countries authors. BMC Public Health. 2018;18(1):961.PubMedPubMedCentralCrossRef
49.
Lupafya PC, Mwagomba BLM, Hosig K, Maseko LM, Chimbali H. Implementation of policies and strategies for control of noncommunicable diseases in Malawi: challenges and opportunities. Health Educ Behav. 2016;43(1_suppl):64S-69S.PubMedCrossRef
50.
Beran D. The Diabetes Foundation Report on implementing national diabetes programmes in sub-Saharan Africa. London: International Insulin Foundation; 2006.
51.
Health MO. Rwanda noncommunicable diseases national strategic plan July 2014–June 2019. Lancet. 2014;381(9866):566–74.
52.
Ministry of Health CD, Gender, Elderly and Children. Strategic plan and action plan for the prevention and control of non communicable diseases in Tanzania 2016–2020. 2016.
53.
Schwartz JI, Dunkle A, Akiteng AR, Birabwa-Male D, Kagimu R, Mondo CK, et al. Towards reframing health service delivery in Uganda: the Uganda initiative for integrated management of non-communicable diseases. Glob Health Action. 2015;8(1):26537.PubMedCrossRef
54.
Organization WH. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. 2007.
55.
Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA, Manthous CA. ATS Documents Development and Implementation Committee. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006;174(5):605–14.PubMedCrossRef
56.
Organization WH. Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the social determinants of health. 2008.
57.
Organization WH. Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies: World Health Organization; 2010.
58.
Services CfMM. National health expenditures fact sheet. 2019.
59.
Hood CM, Gennuso KP, Catlin BB. County health rankings: relationships between determinant factors and health outcomes. Am J Prev Med. 2016;50(2):7.CrossRef
60.
61.
WHO. Time to deliver: report of the WHO independent high-level commission on noncommunicable diseases. World Health Organization; 2018.
62.
Getachew T, Bekele A, Amenu K, Defar A, Teklie H, Taye G, et al. Service availability and readiness for major non-communicable diseases at health facilities in Ethiopia. Ethiop J Health Dev. 2017;31(1):384–90.
63.
Gerba H, Yegezu Y, Ejigu E, G/Giorgis A. Pharmaceutical sector assessment in Ethiopia: food medicine and health care administration and control authority. 2017. p.1–64.
64.
Go K. Kenya service availability and readiness assessment mapping (SARAM). Ministry of Health Nairobi; 2014.
65.
O’Neill K, Takane M, Sheffel A, Abou-Zahr C, Boerma T. Monitoring service delivery for universal health coverage: the Service Availability and Readiness Assessment. Bull World Health Organ. 2013;91:923–31.PubMedPubMedCentralCrossRef
66.
Bintabara D, Mpondo BCT. Preparedness of lower-level health facilities and the associated factors for the outpatient primary care of hypertension: evidence from Tanzanian national survey. PLoS ONE. 2018;13(2):e0192942.PubMedPubMedCentralCrossRef
67.
Mutale W, Bosomprah S, Shankalala P, Mweemba O, Chilengi R, Kapambwe S, et al. Assessing capacity and readiness to manage NCDs in primary care setting: gaps and opportunities based on adapted WHO PEN tool in Zambia. PLoS ONE. 2018;13(8):e0200994-e.CrossRef
68.
Bay N, Juga E, Macuacua C, Joao J, Costa M, Stewart S, et al. Assessment of care provision for hypertension at the emergency Department of an Urban Hospital in Mozambique. BMC Health Serv Res. 2019;19(1):975.PubMedPubMedCentralCrossRef
69.
Leslie HH, Spiegelman D, Zhou X, Kruk ME. Service readiness of health facilities in Bangladesh, Haiti, Kenya, Malawi, Namibia, Nepal, Rwanda, Senegal, Uganda and the United Republic of Tanzania. Bull World Health Organ. 2017;95(11):738.PubMedPubMedCentralCrossRef
70.
Musinguzi G, Bastiaens H, Wanyenze RK, Mukose A, Van Geertruyden JP, Nuwaha F. Capacity of health facilities to manage hypertension in Mukono and Buikwe Districts in Uganda: challenges and recommendations. PLoS ONE. 2015;10(11):e0142312.PubMedPubMedCentralCrossRef
71.
Armstrong-Hough M, Kishore SP, Byakika S, Mutungi G, Nunez-Smith M, Schwartz JI. Disparities in availability of essential medicines to treat non-communicable diseases in Uganda: a poisson analysis using the service availability and readiness assessment. PLoS ONE. 2018;13(2):e0192332.PubMedPubMedCentralCrossRef
72.
Welfare MoHaC. Zimbabwe service availability and readiness assessment. 2015. p. 1–145.
73.
Pfaff C, Scott V, Hoffman R, Mwagomba B. You can treat my HIV-but can you treat my blood pressure? Availability of integrated HIV and non-communicable disease care in northern Malawi. Afr J Primary Health Care Fam Med. 2017;9(1):1–8.
74.
Workie NW, Shroff E, Yazbeck AS, Nguyen SN, Karamagi H. Who needs big health sector reforms anyway? Seychelles’ road to UHC provides lessons for sub-Saharan Africa and Island nations. Health Syst Reform. 2018;4(4):362–71.PubMedCrossRef
75.
Ogola EN, Barasa F, Barasa AL, Gitura BM, Njunguna B, Beaney T, et al. May measurement month 2017: the results of blood pressure screening of 14 845 individuals in Kenya—Sub-Saharan Africa. Eur Heart J Suppl. 2019;21(Supplement_D):D71–3.PubMedPubMedCentralCrossRef
76.
Ndhlovu HLL, Masiye JK, Chinula G, Chirwa M, Mbeba M, Beaney T, et al. May measurement month 2017: results of a blood pressure screening campaign in Malawi—Sub-Saharan Africa. Eur Heart J Suppl. 2019;21(Supplement_D):D74–6.PubMedPubMedCentralCrossRef
77.
Goma FM, Mwewa B, Tembo GK, Kachamba M, Syatalimi C, Simweemba C, et al. May measurement month 2017: blood pressure screening results from Zambia—Sub-Saharan Africa. Eur Heart J Suppl. 2019;21(Supplement_D):D130–2.PubMedPubMedCentralCrossRef
78.
Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions. Intern Emerg Med. 2016;11(3):299–305.PubMedPubMedCentralCrossRef
79.
Steinbrook R. Closing the affordability gap for drugs in low-income countries. N Engl J Med. 2007;357(20):1996–9.PubMedCrossRef
80.
Organization WH. A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. World Health Organization; 2013.
81.
Chow CK, Islam SMS, Farmer A, Bobrow K, Maddision R, Whittaker R, et al. Text2PreventCVD: protocol for a systematic review and individual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseases. BMJ Open. 2016;6(10):e012723.PubMedPubMedCentralCrossRef
82.
Tesfaye B, Haile D, Lake B, Belachew T, Tesfaye T, Abera H. Uncontrolled hypertension and associated factors among adult hypertensive patients on follow-up at Jimma University Teaching and Specialized Hospital: cross-sectional study. Res Rep Clin Cardiol. 2017;8:21.
83.
Galson SW, Staton CA, Karia F, Kilonzo K, Lunyera J, Patel UD, et al. Epidemiology of hypertension in Northern Tanzania: a community-based mixed-methods study. BMJ Open. 2017;7(11):e018829.PubMedPubMedCentralCrossRef
84.
Maginga J, Guerrero M, Koh E, Holm Hansen C, Shedafa R, Kalokola F, et al. Hypertension control and its correlates among adults attending a hypertension clinic in Tanzania. J Clin Hypertens. 2016;18(3):207–16.CrossRef
85.
Kimani S, Mirie W, Chege M, Okube OT, Muniu S. Association of lifestyle modification and pharmacological adherence on blood pressure control among patients with hypertension at Kenyatta National Hospital, Kenya: a cross-sectional study. BMJ Open. 2019;9(1):e023995.PubMedPubMedCentralCrossRef
86.
Singano VH. Knowledge, attitudes and practices on hypertension in hypertensive patients at Kamuzu central hospital in malawi. 臺北醫學大學全球衛生暨發展碩士學位學程學位論文. 2015(2015 年):1–61.
87.
Mosha NR, Mahande M, Juma A, Mboya I, Peck R, Urassa M, et al. Prevalence, awareness and factors associated with hypertension in North West Tanzania. Glob Health Action. 2017;10(1):1321279.PubMedPubMedCentralCrossRef
88.
89.
Asgedom SW, Atey TM, Desse TA. Antihypertensive medication adherence and associated factors among adult hypertensive patients at Jimma University Specialized Hospital, Southwest Ethiopia. BMC Res Notes. 2018;11(1):27.PubMedPubMedCentralCrossRef
90.
Teshome DF, Bekele KB, Habitu YA, Gelagay AA. Medication adherence and its associated factors among hypertensive patients attending the Debre Tabor General Hospital, northwest Ethiopia. Integr Blood Press Control. 2017;10:1–7.PubMedPubMedCentralCrossRef
91.
Gikunda CN, Gitonga L. Patients related factors associated with non-adherence to antihypertensive medication among patients at Chuka referral hospital. Kenya Open J Clin Diagn. 2019;9(3):90–113.CrossRef
92.
Goverwa TP, Masuka N, Tshimanga M, Gombe NT, Takundwa L, Bangure D, et al. Uncontrolled hypertension among hypertensive patients on treatment in Lupane District, Zimbabwe, 2012. BMC Res Notes. 2014;7:703.PubMedPubMedCentralCrossRef
93.
Joho AA. Factors affecting treatment compliance among hypertension patients in three District hospitals-dar es salaam: Muhimbili University of Health and Allied Sciences; 2012.
94.
Mbeba MMK-S. Factors influencing treatment adherence amongst hypertesive patients at Queen Elizabeth Central Hospital, Blantyre, Malawi 2014.
95.
Nielsen JØ, Shrestha AD, Neupane D, Kallestrup P. Non-adherence to anti-hypertensive medication in low-and middle-income countries: a systematic review and meta-analysis of 92443 subjects. J Hum Hypertens. 2017;31(1):14–21.PubMedCrossRef
96.
Macquart de Terline D, Kane A, Kramoh KE, Ali Toure I, Mipinda JB, Diop IB, et al. Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries. PLoS ONE. 2019;14(7):e0219266.PubMedPubMedCentralCrossRef
97.
Mugwano I, Kaddumukasa M, Mugenyi L, Kayima J, Ddumba E, Sajatovic M, et al. Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: a cross sectional study. BMC Res Notes. 2016;9(1):3.PubMedPubMedCentralCrossRef
98.
Mukora-Mutseyekwa FN, Chadambuka EM. Drug adherence behavior among hypertensive out-patients at a tertiary health institution in Manicaland province, Zimbabwe, 2011. Patient Prefer Adherence. 2013;7:65–70.PubMedPubMedCentralCrossRef
99.
Chimberengwa PT, Naidoo M. Knowledge, attitudes and practices related to hypertension among residents of a disadvantaged rural community in southern Zimbabwe. PLoS ONE. 2019;14(6):e0215500.PubMedPubMedCentralCrossRef
100.
Tesfaye A, Kumela K, Wolde M. Blood pressure control associates and antihypertensive pharmacotherapy patterns in Tikur Anbessa general specialized hospital chronic care department, Addis Ababa, Ethiopia. Am J Biomed Life Sci. 2015;3(3):41–8.CrossRef
101.
van der Laan DM, Elders PJM, Boons CCLM, Beckeringh JJ, Nijpels G, Hugtenburg JG. Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens. 2017;31(11):687–94.PubMedCrossRef
102.
Mozaffarian DKM, Ascherio A, Stampfer MJ, Willett WC. Trans-fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601–13.PubMedCrossRef
103.
Sorato MM, Davari M, AbdollahiAsl A. Descriptive evaluation of national and international hypertension treatment guidelines: the guideline quality and comprehensiveness to provide care to adult with hypertension. Clin Med Rev Case Rep. 2020;7(5):1–14.
104.
Hyman DJ, Pavlik VN, Greisinger AJ, Chan W, Bayona J, Mansyur C, et al. Effect of a physician uncertainty reduction intervention on blood pressure in uncontrolled hypertensives—a cluster randomized trial. J Gen Intern Med. 2012;27(4):413–9.PubMedCrossRef
105.
Mungati M, Manangazira P, Takundwa L, Gombe NT, Rusakaniko S, Tshimanga M. Factors affecting diagnosis and management of hypertension in Mazowe District of Mashonaland Central Province in Zimbabwe: 2012. BMC Cardiovasc Disord. 2014;14:102.PubMedPubMedCentralCrossRef
106.
Basopo V, Mujasi PN. To what extent do prescribing practices for hypertension in the private sector in Zimbabwe follow the national treatment guidelines? An analysis of insurance medical claims. J Pharm Policy Pract. 2017;10(1):37.PubMedPubMedCentralCrossRef
107.
Sibomana JP, McNamara RL, Walker TD. Patient, clinician and logistic barriers to blood pressure control among adult hypertensives in rural district hospitals in Rwanda: a cross-sectional study. BMC Cardiovasc Disord. 2019;19(1):231.PubMedPubMedCentralCrossRef
108.
Twagirumukiza M, Annemans L, Kips JG, Bienvenu E, Van Bortel LM. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO’s model list of essential medicines. Tropical Med Int Health. 2010;15(3):350–61.CrossRef
109.
Mocumbi AO. Lack of focus on cardiovascular disease in sub-Saharan Africa. Cardiovasc Diagn Therapy. 2012;2(1):74–7.
110.
Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet. 2016;387(10013):61–9.PubMedCrossRef
111.
Maimaris W, Paty J, Perel P, Legido-Quigley H, Balabanova D, Nieuwlaat R, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med. 2013;10(7):e1001490.PubMedPubMedCentralCrossRef
112.
Vialle-Valentin CE, Serumaga B, Wagner AK, Ross-Degnan D. Evidence on access to medicines for chronic diseases from household surveys in five low-and middle-income countries. Health Policy Plan. 2015;30(8):1044–52.PubMedCrossRef
113.
McSweeney JC, Rosenfeld AG, Abel WM, Braun LT, Burke LE, Daugherty SL, et al. Preventing and experiencing ischemic heart disease as a woman: state of the science: a scientific statement from the American Heart Association. Circulation. 2016;133(13):1302–31.PubMedPubMedCentralCrossRef
114.
Berhe DF, Taxis K, Haaijer-Ruskamp FM, Mulugeta A, Mengistu YT, Mol PGM. Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia. BMJ Open. 2017;7(8):e015743.PubMedPubMedCentralCrossRef
115.
Mbui JM, Oluka MN, Guantai EM, Sinei KA, Achieng L, Baker A, et al. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications. Expert Rev Clin Pharmacol. 2017;10(11):1263–71.PubMedCrossRef
116.
Kumar P. Providing the providers—remedying Africa’s shortage of health care workers. N Engl J Med. 2007;356(25):2564–7.PubMedCrossRef
117.
Schram A, Labonté R, Sanders D. Urbanization and international trade and investment policies as determinants of noncommunicable diseases in Sub-Saharan Africa. Prog Cardiovasc Dis. 2013;56(3):281–301.PubMedPubMedCentralCrossRef
118.
Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382(9890):427–51.PubMedCrossRef
119.
Barker DJ, Eriksson JG, Forsén T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002;31(6):1235–9.PubMedCrossRef
120.
Lartey A. Maternal and child nutrition in Sub-Saharan Africa: challenges and interventions. Proc Nutr Soc. 2008;67(1):105–8.PubMedCrossRef
121.
Bain LE, Awah PK, Geraldine N, Kindong NP, Siga Y, Bernard N, et al. Malnutrition in Sub-Saharan Africa: burden, causes and prospects. Pan Afr Med J. 2013;15(1):120.PubMedPubMedCentral
122.
Sawaya AL, Sesso R, Florêncio TMMT, Fernandes MT, Martins PA. Association between chronic undernutrition and hypertension. Matern Child Nutr. 2005;1(3):155–63.PubMedPubMedCentralCrossRef
123.
Carson AP, Howard G, Burke GL, Shea S, Levitan EB, Muntner P. Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension. 2011;57(6):1101–7.PubMedCrossRef
124.
Howard G, Lackland DT, Kleindorfer DO, Kissela BM, Moy CS, Judd SE, et al. Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med. 2013;173(1):46–51.PubMedPubMedCentralCrossRef
125.
Howard G, Cushman M, Moy CS, Oparil S, Muntner P, Lackland DT, et al. Association of clinical and social factors with excess hypertension risk in black compared with white US adults. JAMA. 2018;320(13):1338–48.PubMedPubMedCentralCrossRef
126.
Whelton PKCR, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–115.PubMed
127.
Cornick R, Picken S, Wattrus C, Awotiwon A, Carkeek E, Hannington J, et al. The Practical Approach to Care Kit (PACK) guide: developing a clinical decision support tool to simplify, standardise and strengthen primary healthcare delivery. BMJ Glob Health. 2018;3(Suppl 5):e000962.PubMedPubMedCentralCrossRef
128.
129.
Oliveira-Filho AD, Barreto-Filho JA, Neves S, Lyra Junior DD. Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) and blood pressure control. Arq Bras Cardiol. 2012;99(1):649–58.PubMedCrossRef
130.
Pladevall M, Brotons C, Gabriel R, Arnau A, Suarez C, de la Figuera M, et al. Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation. 2010;122(12):1183–91.PubMedPubMedCentralCrossRef
131.
Lemstra M, Alsabbagh MW. Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis. Patient Prefer Adherence. 2014;8:211–8.PubMedPubMedCentralCrossRef
132.
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235–481.PubMedCrossRef
133.
Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to medications for cardiovascular diseases in low-and middle-income countries. Circulation. 2016;133(21):2076–85.PubMedPubMedCentralCrossRef
134.
Suleman S, Woliyi A, Woldemichael K, Tushune K, Duchateau L, Degroote A, et al. Pharmaceutical regulatory framework in Ethiopia: a critical evaluation of its legal basis and implementation. Ethiop J Health Sci. 2016;26(3):259–76.PubMedPubMedCentralCrossRef
135.
136.
137.
McNaughton CD, Jacobson TA, Kripalani S. Low literacy is associated with uncontrolled blood pressure in primary care patients with hypertension and heart disease. Patient Educ Couns. 2014;96(2):165–70.PubMedPubMedCentralCrossRef
138.
Darvishpour J, Omidi S, Farmanbar R. The relationship between health literacy and hypertension treatment control and follow-up. Casp J Health Res. 2016;2(1):1–8.CrossRef
139.
Khabala KB, Edwards JK, Baruani B, Sirengo M, Musembi P, Kosgei RJ, et al. Medication Adherence Clubs: a potential solution to managing large numbers of stable patients with multiple chronic diseases in informal settlements. Trop Med Int Health. 2015;20(10):1265–70.PubMedPubMedCentralCrossRef
140.
Organization WH. Tracking universal health coverage: first global monitoring report. World Health Organization; 2015.
141.
Savica V, Bellinghieri G, Kopple JD. The effect of nutrition on blood pressure. Annu Rev Nutr. 2010;30:365–401.PubMedCrossRef
142.
Afshin A, Sur PJ, Fay KA, Cornaby L, Ferrara G, Salama JS, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393(10184):1958–72.CrossRef
Metadata
Title
Reasons for poor blood pressure control in Eastern Sub-Saharan Africa: looking into 4P’s (primary care, professional, patient, and public health policy) for improving blood pressure control: a scoping review
Authors
Mende Mensa Sorato
Majid Davari
Abbas Kebriaeezadeh
Nizal Sarrafzadegan
Tamiru Shibru
Behzad Fatemi
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-01934-6

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue

Research article

Prevalence and associated factors of hypertension among adults with diabetes mellitus in northern Sudan: a cross-sectional study

Research article

Arterial duct stent versus surgical shunt for patients with duct-dependent pulmonary circulation: a meta-analysis

Research

Clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm

Research

Mid-term outcomes of off-pump versus on-pump coronary artery bypass graft surgery; statistical challenges in comparison

Research article

Clinical prediction scores and early anticoagulation therapy for new-onset atrial fibrillation in critical illness: a post-hoc analysis

Research

Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits